Overview

A Study of NPT189 in Healthy Subjects

Status:
Completed

Trial end date:
2019-02-17

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the safety and tolerability of single dose of NPT189 in healthy volunteers. The study will also evaluate the pharmacokinetic characteristics of NPT189.

Phase:

Phase 1

Details

Lead Sponsor:

Proclara Biosciences, Inc.

Treatments:

Immunoglobulin G
Immunoglobulins